APA (7th ed.) Citation

Trenas-Calero, A., Prieto-Laín, N., Gómez-Hernández, A. I., Pérez-Velasco, M. A., Bernal-López, M., López-Carmona, M., . . . Pérez-Belmonte, L. M. (2026). Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study. Pharmaceuticals (14248247), 19(4), 583. https://doi.org/10.3390/ph19040583

Chicago Style (17th ed.) Citation

Trenas-Calero, Alicia, Nuria Prieto-Laín, Ana I. Gómez-Hernández, Miguel A. Pérez-Velasco, María-Rosa Bernal-López, María-Dolores López-Carmona, María-Dolores García de Lucas, Ricardo Gómez-Huelgas, and Luis M. Pérez-Belmonte. "Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study." Pharmaceuticals (14248247) 19, no. 4 (2026): 583. https://doi.org/10.3390/ph19040583.

MLA (9th ed.) Citation

Trenas-Calero, Alicia, et al. "Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study." Pharmaceuticals (14248247), vol. 19, no. 4, 2026, p. 583, https://doi.org/10.3390/ph19040583.